论文信息 - Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC) - 字舞流文

Abstract CT074: Non-comparative, open-label, multiple cohort, phase 1/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): Efficacy and safety in Merkel cell carcinoma (MCC)

D. Schadendorf | U. Martens | S. Topalian | P. Nghiem | A. Awada | W. Sharfman | R. Kudchadkar | A. Hollebecque | A. Gonçalves | A. Oaknin | S. Bhatia | J. Delord | W. Spanos | J. L. Picazo | S. Rao | J. Boer | R. Aljumaily | A. Cao | I. Soumaoro | J. Picazo